SI1411057T1 - - Google Patents

Info

Publication number
SI1411057T1
SI1411057T1 SI200330032T SI200330032T SI1411057T1 SI 1411057 T1 SI1411057 T1 SI 1411057T1 SI 200330032 T SI200330032 T SI 200330032T SI 200330032 T SI200330032 T SI 200330032T SI 1411057 T1 SI1411057 T1 SI 1411057T1
Authority
SI
Slovenia
Application number
SI200330032T
Inventor
Michelle Prudhomme
Bernadette Hugon
Fabrice Anizon
John Hickman
Alain Pierre
Roy Golsteyn
Pierre Renard
Bruno Pfeiffer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SI1411057T1 publication Critical patent/SI1411057T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200330032T 2002-10-16 2003-10-14 SI1411057T1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0212847A FR2845996A1 (fr) 2002-10-16 2002-10-16 Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP03292545A EP1411057B1 (fr) 2002-10-16 2003-10-14 Dérivés de [3, 4 - a:3, 4-c] carbazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
SI1411057T1 true SI1411057T1 (ru) 2005-08-31

Family

ID=29725330

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330032T SI1411057T1 (ru) 2002-10-16 2003-10-14

Country Status (26)

Country Link
US (1) US7151108B2 (ru)
EP (1) EP1411057B1 (ru)
JP (1) JP2004277404A (ru)
KR (1) KR100502250B1 (ru)
CN (1) CN1241925C (ru)
AR (1) AR041618A1 (ru)
AT (1) ATE294181T1 (ru)
AU (1) AU2003254746A1 (ru)
BR (1) BR0304575A (ru)
CA (1) CA2443585A1 (ru)
DE (1) DE60300571T2 (ru)
DK (1) DK1411057T3 (ru)
EA (1) EA007250B1 (ru)
ES (1) ES2240927T3 (ru)
FR (1) FR2845996A1 (ru)
HK (1) HK1063321A1 (ru)
MA (1) MA27007A1 (ru)
MX (1) MXPA03009362A (ru)
MY (1) MY134620A (ru)
NO (1) NO20034614L (ru)
NZ (1) NZ528902A (ru)
PL (1) PL362885A1 (ru)
PT (1) PT1411057E (ru)
SG (1) SG131765A1 (ru)
SI (1) SI1411057T1 (ru)
ZA (1) ZA200308053B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI499414B (zh) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc 鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法
WO2008109591A1 (en) 2007-03-08 2008-09-12 Lexicon Pharmaceuticals, Inc. Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
EP3105225A1 (en) 2014-02-12 2016-12-21 iTeos Therapeutics Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
CN103804278B (zh) * 2014-02-19 2016-04-13 西北大学 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法
MX2016015005A (es) * 2014-05-15 2017-09-28 Iteos Therapeutics Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1.
CA2979616C (en) 2015-03-17 2020-04-28 Pfizer Inc. Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
JP2016216446A (ja) * 2015-05-14 2016-12-22 ファイザー・インク ピロリジン−2,5−ジオン誘導体の多形形態、医薬組成物、およびido1阻害薬としての使用方法
WO2017025868A1 (en) 2015-08-10 2017-02-16 Pfizer Inc. 3-indol substituted derivatives, pharmaceutical compositions and methods for use
CN106832175B (zh) * 2017-02-17 2019-10-18 华南理工大学 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3010675B2 (ja) * 1989-03-23 2000-02-21 萬有製薬株式会社 抗腫瘍性物質be―13793c

Also Published As

Publication number Publication date
PL362885A1 (en) 2004-04-19
SG131765A1 (en) 2007-05-28
DK1411057T3 (da) 2005-08-29
CA2443585A1 (fr) 2004-04-16
ZA200308053B (en) 2004-07-08
PT1411057E (pt) 2005-08-31
US7151108B2 (en) 2006-12-19
AU2003254746A1 (en) 2004-05-06
EP1411057A1 (fr) 2004-04-21
AR041618A1 (es) 2005-05-26
DE60300571T2 (de) 2006-02-23
EA007250B1 (ru) 2006-08-25
MY134620A (en) 2007-12-31
EA200301020A1 (ru) 2004-04-29
DE60300571D1 (de) 2005-06-02
HK1063321A1 (en) 2004-12-24
KR20040034472A (ko) 2004-04-28
ES2240927T3 (es) 2005-10-16
ATE294181T1 (de) 2005-05-15
NO20034614L (no) 2004-04-19
MXPA03009362A (es) 2004-04-28
FR2845996A1 (fr) 2004-04-23
CN1496989A (zh) 2004-05-19
NZ528902A (en) 2004-09-24
KR100502250B1 (ko) 2005-07-20
EP1411057B1 (fr) 2005-04-27
JP2004277404A (ja) 2004-10-07
BR0304575A (pt) 2004-07-20
CN1241925C (zh) 2006-02-15
NO20034614D0 (no) 2003-10-15
US20040077672A1 (en) 2004-04-22
MA27007A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
BE2019C547I2 (ru)
BE2019C510I2 (ru)
BE2018C021I2 (ru)
BE2017C049I2 (ru)
BE2018C018I2 (ru)
BE2014C051I2 (ru)
BE2014C041I2 (ru)
BE2014C030I2 (ru)
BE2014C016I2 (ru)
BE2014C015I2 (ru)
BE2013C063I2 (ru)
BE2013C039I2 (ru)
BE2015C069I2 (ru)
BE2011C038I2 (ru)
JP2003199174A5 (ru)
BRPI0215435A2 (ru)
BE2013C046I2 (ru)
JP2003252281A5 (ru)
JP2003229544A5 (ru)
JP2003179260A5 (ru)
HU0202368D0 (ru)
BR0315835A2 (ru)
JP2003176304A5 (ru)
JP2002204870A5 (ru)
AU2001283830A1 (ru)